Abstract
A 55-year-old Caucasian male developed a well characterized autoimmune hepatitis after completing treatment with pegylated interferon and ribavirin for recurrent hepatitis C. We hypothesize that pegylated interferon triggered a severe form of immune-mediated hepatitis.
MeSH terms
-
Antiviral Agents / adverse effects*
-
Hepatitis C / complications
-
Hepatitis C / drug therapy*
-
Hepatitis, Autoimmune / etiology*
-
Humans
-
Interferon alpha-2
-
Interferon-alpha / adverse effects*
-
Liver Cirrhosis / surgery
-
Liver Transplantation / adverse effects*
-
Male
-
Middle Aged
-
Polyethylene Glycols / adverse effects*
-
Recombinant Proteins
Substances
-
Antiviral Agents
-
Interferon alpha-2
-
Interferon-alpha
-
Recombinant Proteins
-
Polyethylene Glycols
-
peginterferon alfa-2a